Thanks to our sponsors for their continuing support...
The RTP DMDG is a tax-exempt, non-profit organization and does not charge membership fees. Meetings are funded in part through registration fees, but these fees do not cover the travel costs of speakers and venue fees. The organization exists because of generous corporate support.
Because of this financial support, the RTP-DMDG has become a venue where new and experienced scientists in drug metabolism, toxicology, and clinical pharmacology meet to network, share expertise, and acquire knowledge. Corporate sponsors are listed below and are recognized at all meetings during the year of their donation.
If you or your company are interested in supporting the RTP DMDG through a tax-deductible contribution, contact us at email@example.com.
Absorption Systems assists pharmaceutical and medical device companies in identifying and overcoming ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) barriers in the development of drugs and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes whey they occur. The company's facilities are strategically located on both of the US coasts, and encompass nearly 65,000 sq. ft., servicing hundreds of customers throughout the world. For more information on the company's comprehensive contract services and applied research programs, please visit www.absorption.com.
BioIVT is a worldwide provider of biological products to life sciences and pharmaceutical companies. We specialize in control and disease state matrices manufactured from human and animal blood, plasma and serum, which are used in drug discovery, compound development, clinical and research diagnostics. BioIVT's products enable scientists and biomedical researchers to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes.
BioIVT is the premier world provider of specialized in vitro products for the study of metabolism, drug-drug interactions and toxicity in drug discovery and development. Since 1990, pharmaceutical and biotechnology companies have relied on BioIVT for quality in vitro products for lead optimization. We deliver faster time to results, so your research is more productive and cost-effective.
Our experience in preparing and shipping product ensures you of the highest quality primary cells and subcellular fractions for your research. BioIVT cryoplateable hepatocytes (the world's largest inventory) and other ADMET research tools are available worldwide. We also ship fresh plated hepatocytes throughout North America and to Western Europe.
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With over 40 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical Proof-of-Concept, Cardiovascular Safety Services (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies.
Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis, in addition to small and large molecule bioanalytical assays throughout clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings.
For more information please visit www.celerion.com.
Covance Inc., the drug development business of LabCorp®, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®.
Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, along with our innovative technology solutions, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions.
We also offer laboratory testing services to the chemical/agrochemical industries and are a market leader in toxicology services, central laboratory services, discovery services and a top global provider of Phase III clinical trial management services. www.covance.com.
LabLogic Systems, Inc. is a market-leading and award-winning instrument and software provider, supporting pharmaceutical companies, agrochemical research, universities, contract research organizations, positron emission tomography (PET) and nuclear medicine facilities for over 30 years. Our systems for radioisotope detection, radiochromatography and quality control are designed and manufactured to help streamline operations and meet with demanding compliance regulations.
Specialist applications software is a key part of the LabLogic portfolio of products. Designed to drive the range of instruments, analyse and interpret data and integrate with other systems, our software – which includes Laboratory Information Management Systems (LIMS) for drug metabolism studies and radiopharmaceutical production – is used widely in prestigious facilities and recognised as the industry standard in its field.
MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and pharmacokinetic analysis in support of discovery, preclinical and clinical drug development studies. We specialize in method development, validation and sample analysis for small molecules, macromolecules, biomarkers and metabolites using LC/MS/MS, HPLC/UV, immunoassay, multiplex and qPCR techniques. MicroConstants also assembles and distributes protocol-specific specimen collection kits to streamline and simplify the PK collection process for single and multi-site clinical trials.
MicroConstants, Inc. was founded in 1998 in San Diego, California by Gilbert Lam, Ph.D., a veteran in pharmaceutical development and a scientist trained in the field of pharmacokinetics. Our San Diego facility has since grown to become one of the largest bioanalytical LC/MS/MS laboratories on the West Coast of the United States, housing 18 LC/MS/MS systems and occupying 34,000 square feet of office and laboratory space.
PAREXEL provides the most comprehensive drug development capabilities of any CRO worldwide. For over 30 years, we have helped clients get their new and innovative drug treatments into the hands that need them most by simplifying their journey to market. Our global regulatory expertise, Phase I-IV clinical research services, integrated eClinical technologies, and advanced commercialization services all work together to move you through the development journey more smoothly and cost-effectively from beginning to end. Headquartered near Boston, Massachusetts, PAREXEL operates in 80 locations throughout 51 countries, and has over 17,440 employees. For more information about PAREXEL, visit www.PAREXEL.com.
Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) and life sciences products supplier supporting discovery, preclinical, and clinical drug development, providing quality services to pharmaceutical and biotechnology clients worldwide. QPS linearly integrated core competencies include: neuropharmacology, DMPK, liver research, toxicology, bioanalysis, translational medicine, and clinical development. QPS regional laboratories and (pre)clinical testing facilities are located at company headquarters in Newark, DE; Springfield, MO; Fargo, ND; Research Triangle Park, NC; Hollywood, FL; South Miami, FL, USA; Groningen, The Netherlands; Graz, Austria; Hyderabad, India; Barcelona, Spain; and Taipei, Taiwan.
With 20 years of experience and 600 customers in more than 40 countries, SOLVO Biotechnology is the leading provider of transporter services and products. Leveraging our expertise in efflux and uptake transporters, SOLVO generates quality reports for submission to FDA/EMA. From small molecules to protein therapeutics, SOLVO can test all your transporter needs.
XenoTech, LLC is a global Contract Research Organization with unparalleled experience and expertise in evaluating drug candidates, nutraceuticals, cosmetics, food additives and other compounds widely known as xenobiotics, substrates, inhibitors and inducers of cytochrome P450, UGT and other drug metabolizing enzymes and drug transporters. The company offers a variety of in vitro and in vivo safety assessment studies for drug candidate evaluation, as well as an extensive selection of products for drug metabolism research. XenoTech's product selection includes a wide-range of high quality standard reagents, from subcellular fractions and hepatocytes to recombinant enzymes, substrates and metabolites. The company can also prepare and deliver custom-designed products and services in respnose to client requests. For additional information, please refer to the company's website at www.xenotechllc.com or call (913) 438-7450.